A PYMNTS Company

US: Antitrust experts warn against proposed Bayer-Monsanto merger

By  |  August 4, 2016

In a new report, ‘An Antitrust Review of a Bayer-Monsanto Merger’, Washington DC-based Konkurrenz Group warned that the merger, which would create the world’s biggest seed and pesticide business, would violate anti-trust laws and reduce competition.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    The deal would eliminate direct competition between two of the biggest players in the farm supply and seed sector, a report from Konkurrenz stated, affecting seed development, herbicide markets and research and development. The result, it warned, would be less choice and higher food prices for consumers.

    One key issue surrounds Monsanto’s RoundUp, whose only viable competitor at present is Bayer’s Liberty Link. “Not only will a merger end the head-to-head competition between Bayer and Monsanto,” the report stated, “it significantly reduces the incentives to further develop herbicides and herbicide-tolerant traits.”

    Concerns also run high regarding the merger’s impact on the seed market. “Farmers’ choices of seeds they can access will be severely limited after a deal, as more traits, seeds, and herbicides could be foreclosed and squeezed out of the market due to licensing restrictions,” the report argued. “Ultimately, this will reduce consumer choice as upstream market impacts take hold.”

    Bayer’s initial US$62bn bid was publicly rebuffed by Monsanto last month, but Bayer chief executive Werner Baumann insisted that negotiations would continue in private.

    Full Content: Bayer Monsanto Merger

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.